Home › NDC Lookup › Ingredients › Meclizine Hydrochloride › 00536-1299-10
Meclizine Hydrochloride 25 mg Tablet, Chewable, 1,000-count — NDC 00536-1299-10 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Meclizine Hydrochloride 25 mg Tablet, Chewable, 1,000-count — NDC 0536-1299-10 (Billing 00536-1299-10)

by Rugby Laboratories · 1000 TABLET, CHEWABLE in 1 BOTTLE

This is a package of 1,000 tablets of Meclizine Hydrochloride 25 mg Tablet, Chewable from Rugby Laboratories, marketed since Oct 2020 and currently FDA-listed; retail pharmacies pay about $0.0333 per tablet (NADAC).

NDC 00536-1299-10
🏷️ FDA NDC (as labeled) 0536-1299-10 billing pads the labeler segment with a zero
This package
Contains1,000-count Cost per ea$0.0333 NADAC Per package$33.30 / 1000 tablets Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.3154/unit — full pricing hub ↓
Product page 00536-1299-01 Also comes in: 100 tablets 0536-1299-01
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0536-1299-10 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0536 labeler · 1299 product · 10 package
Package marketed since
Nov 9, 2020
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
1,000 EA per package
Barcode (UPC)
0305361299101
Medicaid fills, this package
21,573 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Meclizine Hydrochloride (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Mar 16, 2026 — Failed tablet specifications. (Amerisource Health Services LLC) · FDA recall D-0418-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0536-1299-10
Product NDC 0536-1299
11-digit billing NDC 00536129910
NCPDP billing unit EA — each (per item)
RxCUI 995632
UNII HDP7W44CIO
UPC 0305361299101
Application # M009
SPL Set ID b57f14a7-3852-03db-e053-2a95a90a80d6
Established class (EPC) Antiemetic
Physiologic effect Emesis Suppression
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-10-30
Route ORAL
Dosage form TABLET, CHEWABLE
Substance MECLIZINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 004736
GCN 18312
HICL code 001975
Ingredient (HICL) Meclizine Hcl
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Midbrain
HIC3 code H6J
Therapeutic class — specific (HIC3) Antiemetic/Antivertigo Agents
AHFS code 04:04.16.00
AHFS class Piperazine Derivatives
FDB label name MECLIZINE 25 MG TABLET CHEW
FDB brand name Meclizine Hcl
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 004736
  • GCN: 18312
  • HICL (First Databank): 001975
  • AHFS class code: 04:04.16.00
  • RxCUI (RxNorm): 995632
Why two NDCs? The FDA registers this code as 0536-1299-10 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1299-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Antiemetic class.

Pharmacologic class Antiemetic
Drug family (ATC) Piperazine derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name MECLIZINE 25 MG TABLET CHEW Ingredient Meclizine Hcl
📖 What it is MedlinePlus · NLM

Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Meclizine is mainly used to prevent and treat the nausea, vomiting, and dizziness that comes with motion sickness — whether you're on a boat, in a car, or on a plane. It's also use...
  • For the best chance of preventing motion sickness, take meclizine about one hour before you start traveling. After that first dose, you can take it once every 24 hours as needed fo...
  • Yes, drowsiness is the most common side effect — it's actually worth planning around. Avoid driving or operating heavy machinery until you know how it affects you. And definitely s...
  • This one requires a conversation with your doctor. Human studies haven't clearly linked meclizine to birth defects, but animal studies did show fetal harm at doses similar to what...
📖 Read our full Meclizine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.033 $33.30 / 1000 tablets
Medicaid paysCMS SDUD · 12 mo $0.3154 $315.40 / 1000 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Sep 2022 Feb 2026 Sep 2026 $0.035 $0.032
Flat over the last 20 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00536-1299-01 0536-1299-01 Main listing 100 TABLET, CHEWABLE in 1 BOTTLE $0.0333 / ea $3.33 2020-10-30 — Active
00536-1299-10 You're viewing this 1000 TABLET, CHEWABLE in 1 BOTTLE $0.0333 / ea $33.34 2020-11-09 — Active

You're viewing the largest of 2 pack sizes for this product.

This pack effectively ties for the lowest per-ea cost of the 2 priced pack sizes ($0.0333 NADAC).

This pack accounts for about 46% of this product's recent Medicaid fills; most go to the 100 tablets pack. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 1,000-count package — 1000 tablet, chewable in 1 bottle.
How does this package differ from NDC 00536-1299-01?
Both are Meclizine Hydrochloride 25 mg Tablet, Chewable — the drug itself is identical. This page's package is the 1,000-count one, while NDC 00536-1299-01 is the 100 tablets package.
What NDC number is used to bill for this package of Meclizine Hydrochloride 25 mg Tablet, Chewable?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Meclizine Hydrochloride 25 mgthis 00536-1299-10 Rugby 1000 tablets $0.033 — Availability likely —
Meclizine HCl 25 mg 16571-0824-01 Rising 100 tablets $0.033 — Availability likely —
Motion Sickness Relief 25 mg 46122-0774-51 Amerisource 8 tablets $0.033 — Availability likely —
Motion-Time Chewable 25 mg/251 49483-0333-01 Time-Cap 100 tablets $0.033 — Availability likely —
Meclizine HCl 25 mg 68001-0529-00 BluePoint 100 tablets $0.033 — Availability likely —
Motion Sickness 25 mg 70677-1290-01 Strategic 100 tablets $0.033 — Availability likely —
Travel ease 25 mg 83324-0027-16 Chain 8 tablets $0.033 — Availability likely —
Motion Sickness Relief 25 mg 00363-4040-21 Walgreen 8 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 00363-5172-07 Walgreen 12 tablets — — FDA listed —
Motion Sickness Relief 25 mg 11822-4040-01 Rite 8 tablets — — FDA listed —
Meclizine 25 mg 16103-0387-08 Pharbest 100 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 16571-0663-01 Rising 100 tablets — — FDA listed —
Meclizine HCL 25 mg 17714-0115-01 Advance 100 tablets — — FDA listed —
Meclizine 25 mg 37835-0202-01 Bi-Mart 100 tablets — — FDA listed —
Meclizine 25 mg 43063-0804-01 PD-Rx 100 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 50090-5496-00 A-S 30 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 50090-5952-00 A-S 30 tablets — — FDA listed —
Motion Sickness Relief 25 mg 51013-0322-54 PuraCap 2 tablets — — FDA listed —
Motion Sickness Relief 25 mg 51316-0404-21 CVS 8 tablets — — FDA listed —
Motion Sickness 25 mg 51316-0441-21 CVS 8 tablets — — FDA listed —
Meclizine HCL 25 mg 54738-0025-01 Richmond 100 tablets — — FDA listed —
Dramamine 25 mg 63029-0906-12 Medtech 12 tablets — — FDA listed —
Dramamine 25 mg 63029-0913-12 Medtech 12 tablets — — FDA listed —
Dramamine 25 mg 63029-0914-12 Medtech 12 tablets — — FDA listed —
Bonine 25 mg 65197-0275-02 WellSpring 2 tablets — — FDA listed —
Bonine 25 mg 65197-0296-08 WellSpring 8 tablets — — FDA listed —
Bonine 25 mg 65197-0297-08 WellSpring 8 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 68071-2574-02 NuCare 20 tablets — — FDA listed —
Meclizine HCL 25 mg 68788-7982-01 Preferred 10 tablets — — FDA listed —
Meclizine HCl 25 mg 68788-8529-01 Preferred 10 tablets — — FDA listed —
Meclizine HCL 25 mg 69618-0028-01 Reliable 100 tablets — — FDA listed —
Motion Sickness Relief 25 mg 69842-0395-54 CVS 2 tablets — — FDA listed —
Meclizine HCL 25 mg 71205-0606-30 Proficient 30 tablets — — FDA listed —
Meclizine 25 mg 71335-1215-00 Bryant 120 tablets — — FDA listed —
Meclizine HCL 25 mg 71335-1607-00 Bryant 120 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 71335-2177-00 Bryant 120 tablets — — FDA listed —
Meclizine HCl 25 mg 71335-9751-00 Bryant 120 tablets — — FDA listed —
Meclizine HCL 25 mg 71610-0528-30 Aphena 30 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 71610-0836-30 Aphena 30 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 72789-0250-12 PD-Rx 12 tablets — — FDA listed —
Meclizine 25 mg 80513-0421-02 Advanced 200 tablets — — FDA listed —
Dramamine Chewable Orange 25 mg 63029-0915-08 Medtech 4 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Oct 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color pink
ShapeRound
Imprint5172
Size9 mm
ScoringScored — splits in 2
FlavorRaspberry
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII 2S7830E561
    Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 4N14V5R27W
    A natural flavoring derived from raspberry fruit that gives medicines a pleasant taste. It helps mask bitter or unpleasant flavors to make medications easier to swallow.
  • UNII SB8ZUX40TY
    Saccharin sodium is an artificial sweetener made from saccharin salt. It's added to medicines to improve taste, especially in liquid formulations for children or bitter drugs.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII Q74T35078H
    Vanilla is a flavoring ingredient extracted from vanilla orchid beans. It's added to medicines to improve taste and make them more pleasant to take, especially for children or patients who need liquid formulations.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescroscarmellose sodium, crospovidone, FD&C red #40 lake, french vanilla flavor, lactose, magnesium stearate, raspberry flavor, silica, sodium saccharin, stearic acid.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRugby Laboratories
FDA applicationM009 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedOct 2020
Product typeHuman Otc Drug
Portfolio149 products on file

More NDCs from Rugby Laboratories labeler code 00536

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🆘 Overdosage 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 12 words ▾

Uses prevents and treats nausea, vomiting or dizziness due to motion sickness

⏱️ Dosage and Administration 54 words ▾

Directions  Dosage should be taken one hour before travel starts adults and children 12 years of age and over chew 1 to 2 tablets once daily, or as directed by a doctor children under 12 years of age do not give to children under 12 years of age unless directed by a doctor

⚠️ Warnings 122 words ▾

Warnings Do not use for children under 12 years of age unless directed by a doctor Ask a doctor before use if you have  glaucoma  a breathing problem such as emphysema or chronic bronchitis  trouble urinating due to an enlarged prostate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers When using this product  drowsiness may occur  alcohol, sedatives, and tranquilizers may increase drowsiness  avoid alcoholic drinks  use caution when driving a motor vehicle or operating machinery If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

🆘 Overdosage 16 words ▾

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

🧪 Active Ingredient 12 words ▾

Drug Facts Active ingredient (in each chewable tablet) Meclizine HCl 25 mg

🧪 Inactive Ingredients 22 words ▾

Inactive ingredients croscarmellose sodium, crospovidone, FD&C red #40 lake, french vanilla flavor, lactose, magnesium stearate, raspberry flavor, silica, sodium saccharin, stearic acid.

🎯 Purpose 2 words ▾

Purpose Antiemetic

📄 Do Not Use 15 words ▾

Do not use for children under 12 years of age unless directed by a doctor

📄 Ask a Doctor Before Use If 29 words ▾

Ask a doctor before use if you have  glaucoma  a breathing problem such as emphysema or chronic bronchitis  trouble urinating due to an enlarged prostate gland

📄 Ask a Doctor or Pharmacist Before Use If 14 words ▾

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers

📄 When Using This Product 31 words ▾

When using this product  drowsiness may occur  alcohol, sedatives, and tranquilizers may increase drowsiness  avoid alcoholic drinks  use caution when driving a motor vehicle or operating machinery

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 6 words ▾

Keep out of reach of children.

📄 Other Information 16 words ▾

Other information  Store in a dry place at 15°-30°C (59°-86°F)  keep lid tightly closed

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-231-4670

📄 Package Label / Principal Display Panel 22 words ▾

Rugby NDC 0536-1299-10 compare to the active ingredient in Bonine®* meclizine HCl meclizine HCl 25 mg antiemetic 1000 chewable tablets Rugby label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
21.6K
Units reimbursed last 4 qtrs
999.8K
Gross reimbursed last 4 qtrs
$315.4K
Avg / prescription
$14.62
Avg / unit
$0.3154
Latest quarter Q4 2025
6.6KRx
Medicaid pays / ea
$0.3154
gross reimbursed
vs
NADAC / ea
$0.0333
acquisition cost
=
Spread
+$0.2821
+847% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
82% FFS 18% MCO
Fee-for-service · 17,786 Rx Managed care · 3,787 Rx
State Medicaid map
Alaska: no data reported AK Maine: 4,061 units · 291 per 100k residents ME Washington: 10,625 units · 136 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 8,996 units · 157 per 100k residents MN Wisconsin: 8,465 units · 143 per 100k residents WI Michigan: 6,651 units · 66.3 per 100k residents MI New York: 15,518 units · 79.3 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 2,406 units · 56.8 per 100k residents OR Nevada: 4,024 units · 126 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 5,491 units · 171 per 100k residents IA Illinois: 4,990 units · 39.8 per 100k residents IL Indiana: 2,766 units · 40.3 per 100k residents IN Ohio: 14,201 units · 121 per 100k residents OH Pennsylvania: 36,846 units · 284 per 100k residents PA New Jersey: 6,387 units · 68.8 per 100k residents NJ Massachusetts: 7,234 units · 103 per 100k residents MA California: 763,030 units · 1,958 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 9,913 units · 501 per 100k residents NE Missouri: no data reported MO Kentucky: 45,316 units · 1,001 per 100k residents KY West Virginia: no data reported WV Virginia: 9,146 units · 105 per 100k residents VA Maryland: 1,639 units · 26.5 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 6,348 units · 85.4 per 100k residents AZ New Mexico: 6,958 units · 329 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 605 units · 11.3 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 1,170 units · 10.6 per 100k residents GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 17,013 units · 55.8 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
10.61,958
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 California 1,958 /100k
2 Kentucky 1,001 /100k
3 Nebraska 501 /100k
4 New Mexico 329 /100k
5 Maine 291 /100k
6 Pennsylvania 284 /100k
7 Iowa 171 /100k
8 Minnesota 157 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
100 tablets00536-1299-01 25,470 Rx · $225,377
1000 tablets this page00536-1299-10 21,573 Rx · $315,363
Drug total (last 4 qtrs): 47,043 Rx · 2,166,651 units · $540,740 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
← 00536-1298-01 · Rugby 00536-1302-97 · RUGBY →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.